Wire Stories

APRA AMCOS Taps Klarrio to Accelerate IT Modernisation

Real-Time Streaming-Data Integrator Speeds Record-Matching, Reduces Costs SYDNEY--(BUSINESS WIRE)--APRA AMCOS, a music rights management organisation for Australian and New Zealand…

6 years ago

Accenture Acquires Electro 80 to Help Resources Companies Modernise Operations and Become More Efficient

PERTH, Australia--(BUSINESS WIRE)--Accenture (NYSE: ACN) has acquired Electro 80, a leading provider of operational technology (OT) for resources clients in…

6 years ago

Berkshire Hathaway Specialty Insurance Expands Transactional Liability Team, Naming Daniel Thieviasingham Senior Underwriter, AME

BOSTON & SINGAPORE--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has appointed Daniel Thieviasingham as Senior Underwriter, Transactional…

6 years ago

Nestlé’s new investment projects settled in Guhe Subdistrict, Laixi Qingdao

QINGDAO, China--(BUSINESS WIRE)--On April 27, Nestlé, Laixi Government and Laixi Guhe Subdistrict Office jointly hosted the signing ceremony of new…

6 years ago

Australian Businesses Plan to Bolster Remote Collaboration as They Look Towards a Hybrid Work Future

52% of Respondents Report an Increased Spend on Collaboration, Communication and Productivity Technologies in the Next Year SYDNEY--(BUSINESS WIRE)--Smartsheet (NYSE:SMAR),…

6 years ago

Dialpad Ramps Up Go-To-Market Strategy in New Zealand

Cloud communications leader expects to continue its strong momentum as it increases its presence in New Zealand AUCKLAND, New Zealand--(BUSINESS…

6 years ago

Fabrinet Announces Third Quarter Fiscal Year 2021 Financial Results

Record Third Quarter Revenue of $479.3 Million Exceeds Guidance BANGKOK--(BUSINESS WIRE)--#Fabrinet--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging…

6 years ago

ImmunoMet Therapeutics Granted Fast Track Designation by U.S. FDA for IM156 in Idiopathic Pulmonary Fibrosis

HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced…

6 years ago

Expensify Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

SAN FRANCISCO--(BUSINESS WIRE)--Expensify announced that it has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities…

6 years ago